The Single Nucleotide Polymorphism (SNP) Genotyping Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
The market size of the Single Nucleotide Polymorphism (SNP) Genotyping has seen exponential growth in recent times. It is projected to rise from $10.3 billion in 2024 to $12.37 billion in 2025, representing a compound annual growth rate (CAGR) of 20.1%.
The Single Nucleotide Polymorphism (SNP) Genotyping Global Market is projected to reach a size of $24.95 billion by 2029. The market is also forecasted to grow at a compound annual growth rate (CAGR) of 19.2%.
Download Your Free Sample of the 2025 Single Nucleotide Polymorphism (SNP) Genotyping Market Report and Uncover Key Trends Now!The key drivers in the single nucleotide polymorphism (snp) genotyping market are:
• Growing applications of SNP genotyping in disease research
• Rising demand for precision medicine driving the need for SNP genotyping
• Expansion of biobanking initiatives
• Increased use of SNP genotyping in agriculture for crop improvement
The single nucleotide polymorphism (SNP) genotyping market covered in this report is segmented –
1) By Product: Consumables, Instruments, Services
2) By Technology: TaqMan SNP Genotyping, Mass Array SNP Genotyping, SNP Gene Chip Arrays, Other Technologies
3) By Application: Animal Genetics, Plant Improvement, Diagnostic Research, Pharmaceuticals And Pharmacogenomics, Agricultural Biotechnology, Other Applications
The key trends in the single nucleotide polymorphism (snp) genotyping market are:
• The increasing use of next-generation sequencing is shaping the SNP genotyping market.
• The demand for SNP genotyping in pharmacogenomics is growing.
• The rise of direct-to-consumer genetic testing is an emerging trend.
• A focus on automation and high-throughput genotyping platforms is shaping the future of the market.
The major players in the single nucleotide polymorphism (snp) genotyping market are:
• Thermo Fischer Scientific Inc
North America was the largest region in the single nucleotide polymorphism (SNP) genotyping market in 2024